美国FTC:美多家药物福利管理公司通过抬高药价获利73亿美元

美港电讯
15 Jan

【美国FTC:美多家药物福利管理公司通过抬高药价获利73亿美元】金十数据1月15日讯,美国联邦贸易委员会(FTC)当地时间1月14日发布报告称,美国多家药物福利管理公司通过对治疗癌症和艾滋病的药物收取“巨额加价”,产生超73亿美元收入。FTC点名了CVS健康旗下Caremark、信诺旗下Express Scripts和联合健康集团旗下的Optum,它们管理着美国约80%处方药。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10